As interest grows in the effects of GLP-1based therapies beyond diabetes and obesity, questions are emerging about their potential impact on migraine
The benefits to health have led to the approval of semaglutide for treating kidney and heart fibrosis in the US, but the treatment potential is much wider, opening possibilities for treating cancer, psoriasis, polycystic ovary syndrome, sinus disease, obstructive sleep apnoea, Alzheimers, Parkinsons, liver disease, atherosclerosis (vascular disease) [6], asthma, some forms of nerve damage [2] and more
and cough drops, mints, hard candy and gum for dry mouth (14%)
Potential Negatives There may be concerns regarding the dependency on GLP-1 medications, as the press release emphasizes the need for combined treatment with medication and behavioral support, which could raise questions about the sustainability of the weight loss achieved
Great product and service
"Peptides and Ageing." Neuroendocrinology Letters